- $1.06bn
- $1.26bn
- $272.30m
U.S. STOCKS ON THE MOVE-Walt Disney, Hilton, Oklo
U.S. STOCKS ON THE MOVE-Walt Disney, JD.Com, Cisco Systems
Harrow falls on downbeat Q3 revenue
Harrow Inc reports results for the quarter ended September 30 - Earnings Summary
Brief: Harrow Announces Nashville Expansion
Harrow Inc reports results for the quarter ended in June - Earnings Summary
Harrow Inc expected to post a loss of 20 cents a share - Earnings Preview
Brief: Harrow Provides TRIESENCE Relaunch Update
Brief: MELT PHARMACEUTICALS ANNOUNCES FIRST PATIENT DOSED IN PIVOTAL PHASE 3 PROGRAM OF ITS LEAD PRODUCT CANDIDATE, MELT-300, FOR NEEDLE- AND OPIOID-FREE SEDATION IN PATIENTS UNDERGOING CATARACT SURGERY
Brief: Melt Pharmaceuticals Announces First Patient Dosed in Pivotal Phase 3 Program of Its Lead Product Candidate, MELT-300, for Needle- and Opioid-Free Sedation in Patients Undergoing Cataract Surgery
Brief: Harrow Announces 52-Week Data From VEVYE ESSENCE-2 Open-Label Extension Study
U.S. RESEARCH ROUNDUP- Altus Power, Jack in the Box, Home Depot
U.S. RESEARCH ROUNDUP- Altus Power, Jack in the Box, Home Depot
Harrow Inc reports results for the quarter ended in March - Earnings Summary
Brief: Harrow Names Greg Dipasquale As Senior Vice President, Head Of Commercial
Harrow Inc expected to post a loss of 20 cents a share - Earnings Preview
Harrow Inc reports results for the quarter ended in December - Earnings Summary
Brief: Harrow Inc - QTRLY Net Revenues $36.35 Million Versus $20.3 Million
Brief: Harrow Announces Fourth Quarter And Year-End 2023 Financial Results